Actinium reported data from the Phase III SIERRA trial of Iomab-B for relapsed or refractory acute myeloid leukaemia (r/r AML ...

Novo Nordisk will be initiating a Phase IIb trial of monlunabant to answer some questions about the drug before initiating a pivotal study. Image credit: Shutterstock / Kittyfly. Questions remain over ...

The patients in the trial had previously undergone endocrine-based therapy and at least one other systemic therapy. Credit: Maria Sbytova / Shutterstock. AstraZeneca and Daiichi Sankyo have reported ...

Olanzapine is an atypical antipsychotic and was first approved by the US Food and Drug Administration in 2009 by Eli Lilly. Image credit: Jonathan Weiss / Shutterstock. Teva Pharmaceuticals has shared ...

Summit Therapeutics and Akeso published results for the Phase III HARMONi-2 trial, which tested ivonescimab, a bispecific ...

The trial enrolled 102 patients with metabolic-dysfunction-associated steatohepatitis. Credit: Emily frost / Shutterstock. Aligos Therapeutics has announced positive topline results from the Phase IIa ...

In Part A of the CIRRUS-HCM trial, patients with obstructive HCM received a single dose of 50, 100, or 200mg of EDG-7500. Credit: Inside Creative House/Shutterstock. Edgewise Therapeutics has ...

Antimicrobial drugs are widely used around the world to treat infections. However, the overuse of antimicrobials has resulted ...

The blinded blood pressure monitor and scale allows blind data monitoring, where participants can take readings but not see ...

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be ...

Starton is planning larger Phase II trials for chronic lymphocytic leukaemia (CLL) and multiple myeloma in 2025. Credit: Ground Picture via Shutterstock. Starton Therapeutics has successfully ...

There are a number of ongoing trials in mpox vaccines. Image credit: Shutterstock / Alexander56891. In August 2024, the World Health Organization (WHO) declared mpox a public health emergency of ...